leupeptin has been researched along with Dysembryoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ballou, B; Hakala, TR; Ryser, HJ; Shen, WC | 1 |
| Bokemeyer, C; Gabius, HJ; Hellmann, T; Schmoll, HJ | 1 |
2 other study(ies) available for leupeptin and Dysembryoma
| Article | Year |
|---|---|
Targeting, internalization, and cytotoxicity of methotrexate-monoclonal anti-stage-specific embryonic antigen-1 antibody conjugates in cultured F-9 teratocarcinoma cells.
Topics: Animals; Antibodies, Monoclonal; Glycolipids; Immunoglobulin G; Leucovorin; Leupeptins; Lewis X Antigen; Lysosomes; Methotrexate; Mice; Mice, Inbred BALB C; Teratoma; Thiamine Pyrophosphate; Tritium | 1986 |
Targeting of neoglycoprotein-drug conjugates to cultured human embryonal carcinoma cells.
Topics: Antineoplastic Agents; Cell Line; Cell Survival; Cisplatin; Etoposide; Glycoproteins; Humans; Lectins; Leupeptins; Methotrexate; Pharmaceutical Vehicles; Receptors, Cell Surface; Teratoma | 1987 |